Skip to main content

Allergy Relief

NDC 57344-292 · AAA PHARMACEUTICAL, INC.

Generic nameFexofenadine Hydrochloride
Dosage formTABLET
RouteORAL
Active ingredient(s)FEXOFENADINE HYDROCHLORIDE
Strength180 mg/1
Pharmacologic classHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

57344-292-02 — 1 BLISTER PACK in 1 CARTON (57344-292-02) / 5 TABLET in 1 BLISTER PACK

57344-292-03 — 1 BLISTER PACK in 1 CARTON (57344-292-03) / 5 TABLET in 1 BLISTER PACK

57344-292-04 — 1 BOTTLE, PLASTIC in 1 CARTON (57344-292-04) / 30 TABLET in 1 BOTTLE, PLASTIC

57344-292-06 — 1 BOTTLE, PLASTIC in 1 CARTON (57344-292-06) / 45 TABLET in 1 BOTTLE, PLASTIC

57344-292-17 — 1 BOTTLE, PLASTIC in 1 CARTON (57344-292-17) / 30 TABLET in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55111-783 — Fexofenadine hydrochloride, 55111-784 — Fexofenadine hydrochloride, 55301-847 — fexofenadine hydrochloride, 55319-917 — Fexofenadine hydrochloride, 55319-923 — Fexofenadine HCl, 55319-957 — Fexofenadine HCL, 55319-965 — Fexofenadine HCl, 55910-111 — Fexofenadine hydrochloride, 55910-609 — fexofenadine hydrochloride, 56062-847 — fexofenadine hydrochloride, 57483-230 — Fexofenadine Hydrochloride, 57483-240 — Fexofenadine Hydrochloride, 58602-426 — Fexofenadine Hydrochloride Oral, 58602-807 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-844 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-876 — Fexofenadine Hydrochloride, 58602-877 — Fexofenadine Hydrochloride, 58602-878 — Fexofenadine Hydrochloride, 59726-701 — Fexofenadine HCl, 59726-801 — Fexofenadine HCl, +225 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels